Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Future vaccines against enteric pathogens.

M M Levine¹, R Edelman

¹Department of Medicine, University of Maryland School of Medicine, Baltimore.

Infectious Disease Clinics of North America

|March 1, 1990

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Factors associated with typical enteropathogenic <i>Escherichia coli</i> infection among children <5 years old with moderate-to-severe diarrhoea in rural western Kenya, 2008-2012.

Epidemiology and infection·2020

Same author

Kinetics of maternally-derived serogroup A, C, Y and W-specific meningococcal immunoglobulin G in Malian women and infants.

Vaccine·2019

Same author

Diarrhoea, enteric pathogen detection and nutritional indicators among controls in the Global Enteric Multicenter Study, Kenya site: an opportunity to understand reference populations in case-control studies of diarrhoea.

Epidemiology and infection·2018

Same author

Overexpression of O-polysaccharide chain length regulators in Gram-negative bacteria using the Wzx-/Wzy-dependent pathway enhances production of defined modal length O-polysaccharide polymers for use as haptens in glycoconjugate vaccines.

Journal of applied microbiology·2018

Same author

Biohydrogenation of cholesterol as an index of bacterial 7α-dehydroxylase activity.

Lipids·2016

Same author

Immunization with Ty21a live oral typhoid vaccine elicits crossreactive multifunctional CD8+ T-cell responses against Salmonella enterica serovar Typhi, S. Paratyphi A, and S. Paratyphi B in humans.

Mucosal immunology·2015

Same journal

Prevention and Control of Clostridioides difficile Infection for the Infectious Diseases Clinician.

Infectious disease clinics of North America·2026

Same journal

Infection Control Strategies to Prevent Emergence and Transmission of Resistant Gram-Negative Bacteria.

Infectious disease clinics of North America·2026

Same journal

Preventing the Spread of Tuberculosis in Health Care Settings.

Infectious disease clinics of North America·2026

Same journal

Threats to Success: Principles of Infection Prevention and Control in Health Care Settings, Part 2: Device and Pathogen Management.

Infectious disease clinics of North America·2026

Same journal

Ventilator-Associated Events: Surveillance and Prevention.

Infectious disease clinics of North America·2026

Same journal

Nosocomial Fungal Infections: Epidemiology, Control Strategies, and Prevention of Candida and Other Yeasts.

Infectious disease clinics of North America·2026

See all related articles

Developing vaccines against major diarrheal pathogens like ETEC, EPEC, Shigella, Vibrio cholerae, rotavirus, and Salmonella typhi is crucial. While some vaccines are nearing approval, widespread availability of safe and effective options for all ages remains years away.

Area of Science:

Medical microbiology
Vaccinology
Public health

Background:

Diarrheal diseases pose a significant global health burden, primarily caused by bacterial agents such as enterotoxigenic Escherichia coli (ETEC), enteropathogenic E. coli (EPEC), Shigella, Vibrio cholerae, and the virus rotavirus.
Salmonella typhi is the leading cause of enteric fever worldwide.

Purpose of the Study:

To review the current status of vaccine development for major enteric pathogens.
To highlight the types of vaccine candidates and their administration routes.

Main Methods:

Review of ongoing vaccine development efforts for key diarrheal disease agents.
Categorization of vaccine candidates by type (live oral, inactivated, subunit) and target pathogen.

Related Experiment Videos

Main Results:

Vaccine candidates include live oral vaccines for S. typhi, V. cholerae, Shigella, and rotavirus, and inactivated/subunit vaccines for S. typhi, V. cholerae, and ETEC.
An oral attenuated S. typhi vaccine is nearing commercial license.

Conclusions:

Significant progress is being made in developing vaccines against common diarrheal pathogens.
Further research and clinical trials are necessary to ensure the practical safety and efficacy of these vaccines in diverse populations, particularly children and adults, before widespread implementation.